Fatty acid oxidation-related gene expression

"Fatty acid oxidation-related gene expression" refers to the collective transcriptional activity of genes encoding enzymes and transporters involved in the fatty acid oxidation (FAO) pathway. FAO is essential for cellular ATP production, especially in high-energy organs such as the heart, skeletal muscle, and liver. Regulators include transcription factors such as peroxisome proliferator-activated receptors (PPARα, PPARδ/β, PPARγ), their co-activators (e.g., PGC-1α), and upstream epigenetic and metabolic modulators[1][2][3][4][5]. Altered FAO gene expression has been observed in heart failure (typically downregulated, contributing to a switch to glucose metabolism), and is also implicated in metabolic diseases and cancer. Rather than being a discrete molecule or therapeutic target, it is a functional/metabolic readout or a group of pathway-related genes. Thus, it is not accurate to treat "fatty acid oxidation-related gene expression" as a canonical molecular target; instead, specific enzymes (like CPT1A, ACADs) or regulators (PPARα) within the FAO pathway may serve as drug targets or biomarkers[1][2][3][4][5][6]. Key caveats: - This is not a single molecular entity (receptor, enzyme, transporter, etc.), but a descriptive group/biological process. - Specific drug/biomarker or safety fields cannot be populated for the term itself. - For structured data, individual FAO enzymes or regulators (e.g., "Carnitine palmitoyltransferase 1A", "Peroxisome proliferator-activated receptor alpha") should be used as specific canonical targets.

Other names

Fatty acid oxidation pathway gene expressionFAO gene expression